Theoretically, several possibilities, which are not mutually exclusive, may be involved in the ability of PA to reduce the risk of a clinical presentation of AD: (1) PA directly modifies amyloid and tau metabolism; (2) PA reduces neurodegeneration provoked by the amyloid cascade; and (3) PA enhances brain function. This evidence concerns the gene MAPT and Alzheimer disease.